Radnet Inc(RDNT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:30 PM ET (Korea 9/12 08:30)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.28 | Insider Own | 10.52% | Shs Outstand | 78.7M | Perf Week | 1.17% |
| Market Cap | 5.94B | Forward P/E | 85.14 | EPS next Y | 72.41% | Insider Trans | -0.98% | Shs Float | 70.4M | Perf Month | -1.9% |
| Enterprise Value | 7.70B | PEG | 1.89 | EPS next Q | 0.22 | Inst Own | 103.99% | Short Float | 14.12% | Perf Quarter | 29.71% |
| Income | -0.02B | P/S | 2.62 | EPS this Y | 31.87% | Inst Trans | 3.81% | Short Ratio | 12.17 | Perf Half Y | 26.28% |
| Sales | 2.27B | P/B | 5.42 | EPS next 5Y | 45.04% | ROA | -0.55% | Short Interest | 9.94M | Perf YTD | 5.8% |
| Book/sh | 13.94 | P/C | 8.18 | EPS past 3/5Y | - 3.18% | ROE | -2.08% | 52W High | -12.06% ($85.84) | Perf Year | 2.39% |
| Cash/sh | 9.23 | P/FCF | 82.09 | Sales past 3/5Y | 12.57% 13.74% | ROIC | -0.66% | 52W Low | 48.54% ($50.82) | Perf 3Y | 156.68% |
| Dividend Est. | - | EV/EBITDA | 27.87 | EPS Y/Y TTM | -37.55% | Gross Margin | 4.63% | Volatility(W/M) | 3.69% 3.26% | Perf 5Y | 156.77% |
| Dividend TTM | - | EV/Sales | 3.39 | Sales Y/Y TTM | 18.92% | Oper. Margin | 4.63% | ATR (14) | 2.65 | Perf 10Y | 1005.27% |
| Dividend Ex-Date | - | Quick Ratio | 1.48 | EPS Q/Q | -50.05% | Profit Margin | -0.93% | RSI (14) | 56.95 | Recom | 1.11 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.48 | Sales Q/Q | 24.99% | SMA20 | 0.55% ($75.08) | Beta | 1.4 | Target Price | $94.62 |
| Payout | - | Debt/Eq | 1.99 | Earnings | 2026/8/9 | SMA50 | 8.24% ($69.74) | Rel Volume | 0.75 | Prev Close | $74.28 |
| Employees | 8844 | LT Debt/Eq | 1.9 | EPS/Sales Surpr. | 43.99% 1.94% | SMA200 | 14.48% ($65.94) | Avg Volume(3M) | 0.82M | Price | $75.49 |
| IPO | 1991/2/27 | Option/Short | Yes/Yes | Trades | 9681 | Volume | 610,324 | Change | 1.63% |
Company
RDNT is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🩻 A healthcare company operating one of the largest outpatient imaging diagnostic networks in the United States. It runs outpatient imaging diagnostic centers offering services such as MRI (magnetic resonance imaging) and CT (computed tomography) scans, while also providing AI-based image analysis and early cancer screening solutions. The company is characterized by growth in both imaging diagnostic volume and AI solutions.
Over the past 1 year, roughly in the middle
12% below its 1-year high.
RDNT has weak earning power
4.63% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +31.9% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +156.7% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 104.0%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
RSMC 0.03%
PSCH 0.02%
SMCO 0.02%
XHS 0.02%
FFOX 0.01%It ranks #4 in the industry
Based on market cap of $6B.
RDNT $6B PER -
TMO $225B PER 32.8
DHR $141B PER 35.5
NTRA $47B PER -
FAQ
What kind of company is RDNT?
RDNT belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of RDNT?
The market cap of RDNT is approximately $5.9B, ranking 1,260 within its sector.
What is the 52-week high and low for RDNT?
RDNT has recorded a 52-week high of $85.84 and a low of $50.82.
